Skip to main content
Livermore
Livermore
ZHEN

BBR Partners, LLC

SEC CIK
0001352467
Latest filing
Aug 11, 2026

ALLO holding history

Allogene Therapeutics, Inc. in every 13F filed by BBR Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALLO overviewAll 13F holders of ALLOFull Q2 2026 holdings

Shares (Q2 2026)
28,952
Value
$60.2K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ALLO by BBR Partners, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202628,952$60.2K<0.1%00.0%UnchangedHolders
Q1 202628,952$70.6K<0.1%00.0%UnchangedHolders
Q4 202528,952$39.7K<0.1%00.0%UnchangedHolders
Q3 202528,952$35.9K<0.1%00.0%UnchangedHolders
Q2 202528,952$32.7K<0.1%00.0%UnchangedHolders
Q1 202528,952$42.3K<0.1%00.0%UnchangedHolders
Q4 202428,952$61.7K<0.1%00.0%UnchangedHolders
Q3 202428,952$81.1K<0.1%00.0%UnchangedHolders
Q2 202428,952$67.5K<0.1%00.0%UnchangedHolders
Q1 202428,952$129.4K<0.1%00.0%UnchangedHolders
Q4 202328,952$92.9K<0.1%00.0%UnchangedHolders
Q3 202328,952$91.8K<0.1%00.0%UnchangedHolders
Q2 202328,952$143.9K<0.1%00.0%UnchangedHolders
Q1 202328,952$143.0K<0.1%00.0%UnchangedHolders
Q4 202228,952$182.1K<0.1%00.0%UnchangedHolders
Q3 202228,952$313.0K<0.1%00.0%UnchangedHolders
Q2 202228,952$330.0K<0.1%00.0%UnchangedHolders
Q1 202228,952$264.0K<0.1%−35,053−54.8%ReducedHolders
Q4 202164,005$955.0K0.1%+28,952+82.6%AddedHolders
Q3 202135,053$901.0K0.1%−3,955−10.1%ReducedHolders
Q2 202139,008$1.02M0.1%00.0%UnchangedHolders
Q1 202139,008$1.38M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.